Navigation Links
New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal
Date:5/26/2009

or hypercapnia in unmonitored settings or the absence of resuscitative equipment. NUCYNTA(TM) is contraindicated in patients with suspected or confirmed cases of paralytic ileus. NUCYNTA(TM) is also contraindicated in patients currently using or within 14 days of using monoamine oxidase inhibitors (MAOI) due to potential additive effects on norepinephrine levels, which may result in adverse cardiovascular events.

Respiratory depression is the primary risk of mu-opioid agonists. Respiratory depression occurs more frequently in elderly or debilitated patients and in those suffering from conditions accompanied by hypoxia, hypercapnia, or upper airway obstruction, in whom even moderate therapeutic doses may significantly decrease pulmonary ventilation. NUCYNTA(TM) should be administered with caution to the elderly, debilitated patients, and patients with conditions accompanied by hypoxia, hypercapnia or decreased respiratory reserve such as: asthma, chronic obstructive pulmonary disease or cor pulmonale, severe obesity, sleep apnea syndrome, myxedema, kyphoscoliosis, CNS depression, or coma. In such patients, even usual therapeutic doses of NUCYNTA(TM) may increase airway resistance and decrease respiratory drive to the point of apnea. Alternative non-mu-opioid agonist analgesics should be considered and NUCYNTA(TM) should be employed only under careful medical supervision at the lowest effective dose in such patients. If respiratory depression occurs, it should be treated as any mu-opioid agonist-induced respiratory depression.

Patients receiving other mu-opioid agonist analgesics, general anesthetics, phenothiazines, other tranquilizers, sedatives, hypnotics, or other CNS depressants (including alcohol, other opioids or illicit drugs) concomitantly with NUCYNTA(TM) may exhibit additive CNS depression. Interactive effects resulting in respiratory depression, hypotension, profound sedation, coma or death may result if these drugs
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
2. Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
3. Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US
4. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
5. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
6. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
7. Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting
8. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
9. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
10. Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis
11. Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... LOVELAND, Colo. , May 24, 2013  Heska Corporation ... veterinary diagnostic and specialty products, announced today that Dr. ... executive officer, and Jason Napolitano , executive ... Second Annual Marcum MicroCap Conference, which is being held May ... at the Grand Hyatt Hotel. The Company,s ...
(Date:5/24/2013)... 24, 2013 The potential of ... delivery of therapeutic agents has been receiving undeniable attention ... showing significant promise. The crucial formulation considerations for orally ... play a major role in the efficiency of pulmonary ... development of new formulation techniques and devices in recent ...
(Date:5/23/2013)... 2013 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... President and Chief Executive Officer of Neurocrine Biosciences, will be ... Health Care Conference in Boston.   The live ... Eastern Time / 8:20 a.m. Pacific Time.  The presentation will ... at http://www.neurocrine.com . If you are ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2
... is pleased to announce that Dr. Andrea Zobel has ... CTD Operations.  In this capacity she will assume responsibility ... operated Clinical Trial Depots once they are ... relationship with their affiliate depot network. (Logo:  ...
... 2012 What:   Life Technologies Unveils ... (CES) in Las Vegas.  The Ion Proton™ Sequencer is designed ... When:   Tuesday, January 10th thru Friday, ... Where:   Las Vegas Convention Center, North Hall, Booth #3438 ...
Cached Medicine Technology:Marken Strengthens Clinical Trial Distribution Capabilities 2
(Date:5/25/2013)... This week idcloak Technologies releases a list of IP ... the site is blocked. When IP proxies are used ... site compatibility problems associated with regular proxy sites. Gill-Chris Welles, ... may apply IP Port proxies to create a proxy ... are. , “When a user takes an IP address and ...
(Date:5/25/2013)... Mansfield, MA (PRWEB) May 25, 2013 Imagine ... long -- the energy loss, hot air and wasted energy! ... whole house fan, a fireplace or clothes dryer, that may ... , Drafts from these often overlooked holes waste energy in ... source of heating and cooling loss in the home. , ...
(Date:5/25/2013)... It's not astonishing that holidays are amongst the most ... from family, friends and co-workers. Between the parties to ... their parents can afford, parties to arrange, and so ... anniversaries and it seems like an eternal cycle of ... and income can’t catch up to the expenses of ...
(Date:5/25/2013)... 25, 2013 An experienced Chandler dentist ... partnership with JD Media Surge, LLC. , ... available and, depending on the treatment, can be performed ... visit, the best method will be chosen for the ... a visit. A special peroxide-based whitening gel is used ...
(Date:5/25/2013)... Communities of Distinction TV announces May air ... media market in the United States with almost three million ... Texas and a major convention city. Ft. Worth is known ... is home to many major museums. Both cities offer a ... arts. Residents and locals will be able to watch the ...
Breaking Medicine News(10 mins):Health News:idcloak Launches Proxy Web Browser for Blocked Facebook Users 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 2Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 3Health News:How To Stop Drafts and Save On Home Energy Bills This Summer - New Draft Stoppers Now Available From Battic Door Energy Conservation 4Health News:TheBeautyPlace.com Debuts Their Brand New Beauty Kits 2Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2
... exercises, quits smoking, stops drinking alcohol, receives a flu shot, ... likely to do the same, according to a new study ... spouse improves his or her health behavior, the other spouse ... Sindelar, health economist and public health professor in the Yale ...
... be sharply divided in their views on many aspects of ... strong agreement when it comes to one of the most ... to results of the American College of Surgeons (ACS) new ... the establishment of a nationwide trauma system - including strong ...
... Oct. 3 SearchMedica.com, the,specialty-oriented professional medical ... of Family Physicians, Scientific Assembly that it ... medicine and family,practitioners to sort results by ... most relevant professional medical information, it now ...
... pregnant women consuming a typical,western diet obtain too little ... is critical for fetal and infant brain,development. This was ... of nutrition experts summarized in the September 2007,Fats of ... pregnant and lactating women to consume at least 200 ...
... Former Procter & Gamble security executive has agreed to work with ... ... Program(TM)., PRINCETON, N.J., Oct. ... channel integrity and create,business value for pharmaceutical, biotech, and medical device ...
... Care a Top ... Priority at Newton-Wellesley, RESTON, Va. ... today announced Newton-Wellesley,s use of,the Isabel decision support system to ... care, the implementation,kicks off an initiative to affirm the quality ...
Cached Medicine News:Health News:A nation divided over health care? Not so fast 2Health News:SearchMedica Finds Most Relevant and Now Most Recent Search Results 2Health News:SearchMedica Finds Most Relevant and Now Most Recent Search Results 3Health News:Brain, Eye and Heart Health: Three Reasons to Eat More Omega-3s 2Health News:IntegriChain Enlists Ed Casey and Associates to Drive Counterfeit and Diversion Monitoring Service 2Health News:Newton-Wellesley Hospital First in Massachusetts to Implement Isabel Diagnosis Decision Support System 2Health News:Newton-Wellesley Hospital First in Massachusetts to Implement Isabel Diagnosis Decision Support System 3
Long handle occluders are approximately 9 inches long....
Manual Lensmeter....
Lightweight, cordless lensmeter....
... 101 is well suited for measuring ... well as conventional spectacle lenses. It ... a full 90-degree inclination, which facilitates ... used in the vertical position. The ...
Medicine Products: